Now Accepting Submissions for Novel hMSC Applications in Europe and North America
Application Deadline: May 31st, 2022
Award Total: Up to $10,000 in applicable RoosterBio® products to be used over a 12 month period
Human mesenchymal stromal cells (hMSCs) are a critical raw material for a growing number of emerging regenerative medicine (RM) applications including cell and gene therapies, engineered tissues, combination products/medical devices, and exosome / extracellular vesicle (EV) based therapies. ...